Alex Carchidi
Alex Carchidi is a contributing Healthcare and Cryptocurrency Analyst at The Motley Fool, covering publicly traded companies and investments in the biotech, pharma, cannabis, and digital asset industries. Prior to The Motley Fool, Alex was a bench scientist and later a science writer at several biopharma companies, and started his career as a researcher at the Ragon Institute of MGH, MIT, and Harvard. He holds a B.A. in Biology and a B.A. in Philosophy from Boston University, and an MBA with a concentration in Finance from the Isenberg School of Business at the University of Massachusetts, Amherst. In his spare time, Alex enjoys traveling in Latin America and exploring the food scene of Greater Boston.
Recent Articles by Alex Carchidi

Solana Is Poised for a Monster Move

Are We in a Crypto Bubble?

Is Chainlink's Latest Move Bearish For XRP (Ripple)?

Prediction: Solana Will Be Worth $500 Within 5 Years

3 Reasons to Buy Bitcoin Before March 2028

Is Bitcoin Going to Surge in July?

XRP vs. Bitcoin: Which Is the Better Buy Right Now?

Prediction: Bitcoin Will Become a Reserve Currency
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.